|Daily Range||$27.83 - $28.99|
|52-Week Range||$19.31 - $29.00|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||208,430|
|Current FY EPS||$1.27|
Emergent BioSolutions (EBS) Description
Emergent BioSolutions makes the only FDA-approved anthrax vaccine. Website: http://www.emergentbiosolutions.com/
News & Commentary
You don't want to miss out on these tiny biotechs expected to see earnings grow sharply in 2015.
Catamaran Corp., Cantel Medical, and Emergent BioSolutions all gained ground during the Great Recession, suggesting that they might be good stocks to watch if markets head south.
Emergent BioSolutions' upfront payment from its deal with MorphoSys caused a large increase in revenue in the third quarter.
These three biotech companies may benefit if short sellers reverse course.